Search

everythinglearnresearchcommunity

for

Search:↓

Scalp threading with polydioxanone threads is a promising, effective, and safe method for hair regrowth.

A 55-year-old woman with several health conditions did not see hair regrowth after a transplant.

Optimal storage solutions and effective additives are crucial for improving the survival of hair transplant grafts.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

Low-dose oral minoxidil safely treats hair loss, with hypertrichosis as main side effect.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

A new topical solution safely reduces hair shedding by 38% on average by tightening a muscle in the scalp.

Surgical hair restoration involves moving hair from a non-balding area to a balding area, with the transplanted hair not subject to male pattern baldness. Medications can slow hair loss and regrow some hair, but successful treatment needs careful planning, skill, and ethical responsibility due to progressive hair loss and limited donor hair.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

Using oral minoxidil and dutasteride together can quickly increase hair growth and volume with minimal side effects.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Topical minoxidil and dietary supplements improved hair regrowth in children with hair loss from chemotherapy.

Oral sturgeon oil promotes hair growth and improves gut health.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Hair restoration surgery can lead to swelling, infections, scarring, numbness, hiccups, and poor hair growth.

The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Cyclosporin doesn't stop hair loss.

Hair restoration surgery redistributes existing hair to achieve a natural look, with visible regrowth in 3-4 months and rare complications, mostly aesthetic.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

The conclusion is that different blood diseases cause specific oral symptoms and require varied treatments to manage these symptoms and improve patient health.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.